BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1367575)

  • 1. IgG production in hybridoma batch culture: kinetics of IgG mRNA, cytoplasmic-, secreted- and membrane-bound antibody levels.
    Leno M; Merten OW; Vuillier F; Hache J
    J Biotechnol; 1991 Oct; 20(3):301-11. PubMed ID: 1367575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Monoclonal antibody metabolism during the growth of hybridoma cells].
    Morenkov OS; Mantsygin IuA; Lezhenev EI
    Tsitologiia; 1988 May; 30(5):611-5. PubMed ID: 2972097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Batch production and secretion kinetics of hybridomas: pulse-chase experiments.
    Merten OW; Keller H; Cabanié L; Leno M; Hardefelt M
    Cytotechnology; 1990 Jul; 4(1):77-89. PubMed ID: 1366724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of flow cytometric measurement of surface IgG in kinetic analysis of monoclonal antibody synthesis and secretion by murine hybridoma cells.
    Meilhoc E; Wittrup KD; Bailey JE
    J Immunol Methods; 1989 Jul; 121(2):167-74. PubMed ID: 2760464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for posttranscriptional stimulation of monoclonal antibody secretion by L-glutamine during slow hybridoma growth.
    Flickinger MC; Goebel NK; Bibila T; Boyce-Jacino S
    J Biotechnol; 1992 Feb; 22(3):201-26. PubMed ID: 1367980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between hybrid mouse monoclonal antibodies and the human high-affinity IgG FcR, huFc gamma RI, on U937. Involvement of only one of the mIgG heavy chains in receptor binding.
    Koolwijk P; Spierenburg GT; Frasa H; Boot JH; van de Winkel JG; Bast BJ
    J Immunol; 1989 Sep; 143(5):1656-62. PubMed ID: 2527269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell cycle kinetics of the accumulation of heavy and light chain immunoglobulin proteins in a mouse hybridoma cell line.
    Kromenaker SJ; Srienc F
    Cytotechnology; 1994; 14(3):205-18. PubMed ID: 7765591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variations in the secretion of monoclonal antibodies by human-human hybridomas.
    Gaffar SA; Surh CD; Glassy MC
    Hybridoma; 1986; 5(2):93-105. PubMed ID: 3721525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential of flow cytometric analysis for the characterization of hybridoma cells in suspension cultures.
    Coco-Martin JM; Oberink JW; van der Velden-de Groot TA; Beuvery EC
    Cytotechnology; 1992; 8(1):65-74. PubMed ID: 1368406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms and kinetics of monoclonal antibody synthesis and secretion in synchronous and asynchronous hybridoma cell cultures.
    al-Rubeai M; Emery AN
    J Biotechnol; 1990 Oct; 16(1-2):67-85. PubMed ID: 1366816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The production of monoclonal antibody in growth-arrested hybridomas cultivated in suspension and immobilized modes.
    Seifert DB; Phillips JA
    Biotechnol Prog; 1999; 15(4):655-66. PubMed ID: 10441357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of endogenous proteins on growth and antibody productivity in hybridoma batch cultures.
    Farrell PJ; Kalogerakis N; Behie LA
    Cytotechnology; 1994; 15(1-3):95-102. PubMed ID: 7765957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cultivation of the hybridoma cell line MN12 in a homogeneous continuous culture system: effect of culture age.
    Coco-Martin JM; Martens DE; van der Velden-de Groot TA; Beuvery EC
    Cytotechnology; 1993; 13(3):213-20. PubMed ID: 7764662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of buffering conditions and culture pH on production rates and glycosylation of clinical phase I anti-melanoma mouse IgG3 monoclonal antibody R24.
    Müthing J; Kemminer SE; Conradt HS; Sagi D; Nimtz M; Kärst U; Peter-Katalinić J
    Biotechnol Bioeng; 2003 Aug; 83(3):321-34. PubMed ID: 12783488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning, reformatting, and small-scale expression of monoclonal antibody isolated from mouse, rat, or hamster hybridoma.
    Loyau J; Rousseau F
    Methods Mol Biol; 2014; 1131():207-28. PubMed ID: 24515468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perfusion culture of hybridoma cells for hyperproduction of IgG(2a) monoclonal antibody in a wave bioreactor-perfusion culture system.
    Tang YJ; Ohashi R; Hamel JF
    Biotechnol Prog; 2007; 23(1):255-64. PubMed ID: 17269696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Model-based monitoring and control of a monoclonal antibody production process.
    Biener RK; Waldraff W; Noé W; Haas J; Howaldt M; Gilles ED
    Ann N Y Acad Sci; 1996 May; 782():272-85. PubMed ID: 8659904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetic studies of cellular metabolic activity, specific IgG production rate, IgG mRNA stability and accumulation during hybridoma batch culture.
    Leno M; Merten OW; Hache J
    Enzyme Microb Technol; 1992 Feb; 14(2):135-40. PubMed ID: 1368396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Russell body phenotype is preferentially induced by IgG mAb clones with high intrinsic condensation propensity: relations between the biosynthetic events in the ER and solution behaviors in vitro.
    Hasegawa H; Woods CE; Kinderman F; He F; Lim AC
    MAbs; 2014; 6(6):1518-32. PubMed ID: 25484054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibody: high density culture of hybridoma cells and downstream processing for IgG recovery.
    Kundu PK; Prasad NS; Datta D
    Indian J Exp Biol; 1998 Feb; 36(2):125-35. PubMed ID: 9754040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.